Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03598244
Title Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

brain stem glioma

high grade glioma

central nervous system cancer

medulloblastoma

Therapies

Savolitinib

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.